Aurélien Jacob
Impact in
- Genetics top 10%
- Virus-based gene therapy research
- Hemoglobinopathies and Related Disorders
Papers in
-
- CRISPR and Genetic Engineering 7
- Insect Resistance and Genetics 2
- Viral Infectious Diseases and Gene Expression in Insects 2
- Genetics 9
- Virus-based gene therapy research 9
- Co-authors
- Samuele Ferrari (8 shared papers)Pietro Genovese (5 shared papers)Luigi Naldini (7 shared papers)Luisa Albano (6 shared papers)Valentina Vavassori (6 shared papers)Ivan Merelli (3 shared papers)Stefano Beretta (3 shared papers)Giulia Schiroli (2 shared papers)
- Journals
- Science Translational Medicine (1 paper)The EMBO Journal (1 paper)Cell stem cell (1 paper)Biotechnology Journal (1 paper)Cell (1 paper)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Aurélien Jacob
10 papers receiving 571 citations
Peers
Comparison fields: 5 of 44
- Business and International Management 23
- Genetics 316
- Molecular Biology 488
- Aging 11
- Oncology 168
Countries citing papers authored by Aurélien Jacob
This map shows the geographic impact of Aurélien Jacob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélien Jacob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélien Jacob more than expected).
Fields of papers citing papers by Aurélien Jacob
This network shows the impact of papers produced by Aurélien Jacob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélien Jacob. The network helps show where Aurélien Jacob may publish in the future.
Co-authors
The 25 scholars most cited alongside Aurélien Jacob, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 203 | |
| 2 | 2017 | 159 | |
| 3 | 2020 | 108 | |
| 4 | 2022 | 36 | |
| 5 | 2021 | 30 | |
| 6 | 2021 | 13 | |
| 7 | 2021 | 9 | |
| 8 | 2020 | 9 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 3 |
About Aurélien Jacob
Aurélien Jacob is a scholar working on Molecular Biology, Genetics, Oncology, Epidemiology and Hematology, having authored 10 papers that have together received 575 indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), CRISPR and Genetic Engineering (7 papers), CAR-T cell therapy research (4 papers), Cytomegalovirus and herpesvirus research (2 papers), Insect Resistance and Genetics (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Immunodeficiency and Autoimmune Disorders (1 paper) and Hematopoietic Stem Cell Transplantation (1 paper). The work is most often cited by research in Business and International Management (23 citations), Genetics (316 citations), Molecular Biology (488 citations), Aging (11 citations) and Oncology (168 citations). Aurélien Jacob has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Samuele Ferrari, Pietro Genovese, Luigi Naldini, Luisa Albano, Valentina Vavassori, Ivan Merelli, Stefano Beretta, Giulia Schiroli, Chiara Brombin and Maria Carmina Castiello. Their work appears in journals such as Science Translational Medicine, The EMBO Journal, Cell stem cell, Biotechnology Journal and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.